MBOT
Microbot Medical Inc.
There isn't enough reported data to score MBOT yet.
MBOT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MBOT's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
MBOT PE Valuation
MBOT has no meaningful PE right now: it lost money over the past year.
MBOT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect MBOT's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MBOT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.24 | +$0.33 |
| Q1 2026 | -$0.26 | +$0.38 |
| Q4 2025 | -$0.29 | +$0.44 |
| Q3 2025 | -$0.44 | +$0.33 |
| Q2 2025 | -$0.57 | +$0.21 |
| Q1 2025 | -$0.64 | +$0.22 |
| Q4 2024 | -$0.73 | +$0.32 |
| Q3 2024 | -$0.77 | +$0.46 |
MBOT is still losing money, but far less than before: $0.24 per share over the past year, against $3.04 at its worst in late 2019.
MBOT Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2568% | N/A |
| Q1 2026 | -4114% | N/A |
MBOT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.1M | -$2.5M |
| Q1 2026 | -$5.2M | -$2.3M |
| Q4 2025 | -$3.8M | -$2.1M |
| Q3 2025 | -$3.9M | -$1.1M |
| Q2 2025 | -$2.6M | -$621K |
| Q1 2025 | -$2.9M | -$453K |
| Q4 2024 | -$1.7M | +$118K |
| Q3 2024 | -$2.8M | -$1.1M |
MBOT has burned cash in almost every quarter: −$18M over the past year, against −$10M the year before.
MBOT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +5.6K shares |
| 1 year | +116% | +36.1M shares |
| 3 years | +845% | +60.1M shares |
| 5 years | +845% | +60.1M shares |
| Available history | +1459% | +62.9M shares |
MBOT has 67M diluted shares, up 116% from a year ago.
MBOT Net Leverage
MBOT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MBOT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 14.2 | Oversold |
MBOT's weekly RSI is 33 (neutral) and its Stochastic is 14 (oversold).
MBOT PE vs Healthcare Sector
MBOT has no meaningful PE right now: it lost money over the past year.
MBOT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 4.6% below |
| 20 week MA | $1.42 | 27% below |
| 50 week MA | $1.85 | 44% below |
| 100 week MA | $2.12 | 51% below |
| 200 week MA | $1.84 | 44% below |
MBOT is in a downtrend: it's below all five of its weekly moving averages, and 44% below its 200-week average.
MBOT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.1 | $7.53 | -32% |
| 2021 | $7.53 | $5.42 | -28% |
| 2022 | $5.42 | $3.40 | -37% |
| 2023 | $3.40 | $1.64 | -52% |
| 2024 | $1.64 | $1.11 | -32% |
| 2025 | $1.11 | $2.15 | +94% |
| 2026 YTD | $2.15 | $1.03 | -52% |
MBOT has finished lower in five of the last six years. It's down 52% so far in 2026.